AML Risk Stratification Gene Panel

Support precision diagnosis and treatment planning with the AML Risk Stratification Gene Panel at Lucid Medical Diagnostics in Hyderabad. This advanced molecular genetic test analyzes clinically significant gene mutations associated with Acute Myeloid Leukemia (AML) to assess disease prognosis, classify risk categories, and guide personalized treatment decisions. The panel helps identify genetic alterations that influence therapeutic response, disease progression, and overall clinical management. Using state-of-the-art molecular diagnostic technology and stringent quality standards, our experienced laboratory team delivers accurate, reliable, and timely results. At Lucid Medical Diagnostics, we provide comprehensive genetic insights to support informed clinical decisions and improve outcomes for patients with Acute Myeloid Leukemia.

Home Sample Collection Available
Get Reports